A Clinical Study To Evaluate The Efficacy of Ayastiladi Modak in the management of Garbhini Pnadu(Anemia In Pregnancy). - NI

Dr Vikrant0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年9月18日

试验速览

暂无简介。

•1 Patients fulfilling Diagnostic criteria.
•2 Pregnant women, belonging to the age group of 21 to 40 years.
•3 Patients having clinical signs and symptoms of Garbhini Pandu, i.e., Panduta (pallor), Bhrama(giddiness), Daurbalya (general weakness), Shwasa (dyspnea) etc.
•4 Patients of second or third trimester of pregnancy with 7 gm% to 10 g% of hemoglobin
•5 Primi-Gravida and Multigravida.

•1 First trimester of pregnancy
•2 Pregnant women coming with more than 30 weeks of gestational age for the first ANC visit.
•3 Patients suffering from pregnancy- related complications such as pregnancy- induced hypertension, hyper emesis gravidarum, pre-eclampsia, etc.
•4 Patients having Hb% count less than 7gm% or more than 10gm%.
•5 Patients with having Heredity Disorders like Sickle cell anemia , Thalessemia etc.
•6 Patients having on long term medication for any specific disease.

发起方

Dr Vikrant